Skip to main content
SpringerLink
Log in

Immunomodulatory effects of docetaxel on human lymphocytes

  • Published:
Investigational New Drugs Aims and scope Submit manuscript

Abstract

Docetaxel is an antineoplastic taxoid that interferes with microtubule polymerization dynamics and is used clinically to treat advanced cancers. Because microtubules play significant roles in T lymphocyte activation and function we characterized the in vitro immunomodulatory properties of docetaxel. Effects of docetaxel on lectin-induced peripheral blood mononuclear cell (PBMC) proliferation were measured by the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay and proliferating cell nuclear antigen (PCNA) staining. In addition, apoptosis was measured by annexin V staining and cell activation by determination of CD25 and CD71 cell surface expression. Intracellular calcium kinetics in lectin-activated Jurkat T lymphocytes exposed to docetaxel were investigated. Th1 cytokine production was assessed in T lymphocytes by intracellular cytokine staining. Docetaxel significantly inhibited PBMC proliferation and promoted apoptosis of lectin-activated PBMCs. Docetaxel significantly decreased expression of CD71 but not that of CD25. Docetaxel altered intracellular calcium homeostasis but did not affect Th1 cytokine production in T lymphocytes. In conclusion we demonstrate that docetaxel, although exerting significant antiproliferative effects on lymphocytes and promoting activation-induced apoptosis does affect only partially lymphocyte activation and function and does not affect Th1 cytokine production. These results suggest maintenance of lymphocyte functions important for host tumor surveillance and suggest that this compound may have a role in the treatment of cancer arising organ transplant recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Salminen E, Bergman M, Huhtala S, Jekunen A, Ekholm E: Docetaxel, a promising novel chemotherapeutic agent in advanced breast cancer. Anticancer Res 20: 3663–3668, 2000

    Google Scholar 

  2. Mattson K, Bosquee L, Dabouis G, Le Groumellec A, Pujol JL, Marien S, Stupp R, Douillard JY, Bragas B, Berille J, Olivares R, Le Chevalier T: Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice. Lung Cancer 29: 205–216, 2000

    Google Scholar 

  3. Glisson BS: The role of docetaxel in the management of squamous cell cancer of the head and neck. Oncology (Huntingt) 16: 83–87, 2002

    Google Scholar 

  4. Hensley ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C, Sabbatini P, Tong W, Barakat R, Spriggs DR: Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20: 2824–2831, 2002

    Google Scholar 

  5. Lenzi R, Yalcin S, Evans DB, Abbruzzese JL: Phase II study of docetaxel in patients with pancreatic cancer previously untreated with cytotoxic chemotherapy. Cancer Invest 20: 464–472, 2002

    Google Scholar 

  6. Pectasides D, Glotsos J, Bountouroglou N, Kouloubinis A, Mitakidis N, Karvounis N, Ziras N, Athanassiou A: Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial. Ann Oncol 13: 243–250, 2002

    Google Scholar 

  7. Verweij J, Clavel M, Chevalier B: Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind. Ann Oncol 5: 495–505, 1994

    Google Scholar 

  8. Kuhn JR, Poenie M: Dynamic polarization of the microtubule cytoskeleton during CTL-mediated killing. Immunity 16: 111–121, 2002

    Google Scholar 

  9. Volkov Y, Long A, Kelleher D: Inside the crawling T cell: leukocyte function-associated antigen-1 cross-linking is associated with microtubule-directed translocation of protein kinase C isoenzymes beta(I) and delta. J Immunol 161: 6487–6495, 1998

    Google Scholar 

  10. Sedwick CE, Morgan MM, Jusino L, Cannon JL, Miller J, Burkhardt JK: TCR, LFA-1, and CD28 play unique and complementary roles in signaling T cell cytoskeletal reorganization. J Immunol 162: 1367–1375, 1999

    Google Scholar 

  11. Akalin E, Hancock WW, Perico N, Remuzzi G, Imberti O, Carpenter CB, Sayegh MH: Blocking cell microtubule assembly inhibits the alloimmune response in vitro and prolongs renal allograft survival by inhibition of Th1 and sparing of Th2 cell function in vivo. J Am Soc Nephrol 5: 1418–1425, 1995

    Google Scholar 

  12. Cao L, Sun D, Cruz T, Moscarello MA, Ludwin SK, Whitaker JN: Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel. J Neuroimmunol 108: 103–111, 2000

    Google Scholar 

  13. Chuang LT, Lotzova E, Heath J, Cook KR, Munkarah A, Morris M, Wharton JT: Alteration of lymphocyte microtubule assembly, cytotoxicity, and activation by the anticancer drug taxol. Cancer Res 54: 1286–1291, 1994

    Google Scholar 

  14. Lee M, Yea SS, Jeon YJ: Paclitaxel causes mouse splenic lymphocytes to a state hyporesponsive to lipopolysaccharide stimulation. Int J Immunopharmacol 22: 615–621, 2000

    Google Scholar 

  15. Mullins DW, Koci MD, Burger CJ, Elgert KD: Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation. Immunopharmacol Immunotoxicol 20: 473–492, 1998

    Google Scholar 

  16. Ostermann D, Perico N, Imberti O, Barbui C, Bontempelli M, Remuzzi G: Colchicine allows prolonged survival of highly reactive renal allograft in the rat. J Am Soc Nephrol 4: 1294–1299, 1993

    Google Scholar 

  17. Tange S, Scherer MN, Graeb C, Weiss T, Justl M, Frank E, Andrassy J, Jauch KW, Geissler EK: The antineoplastic drug Paclitaxel has immunosuppressive properties that can effectively promote allograft survival in a rat heart transplant model. Transplantation 73: 216–223, 2002

    Google Scholar 

  18. Bogdan C, Ding A: Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor alpha and interleukin-1 in macrophages. J Leukoc Biol 52: 119–121, 1992

    Google Scholar 

  19. Grunberg E, Eckert K, Maurer HR: Docetaxel treatment of HT-29 colon carcinoma cells reinforces the adhesion and immunocytotoxicity of peripheral blood lymphocytes in vitro. Int J Oncol 12: 957–963, 1998

    Google Scholar 

  20. Lee LF, Haskill JS, Mukaida N, Matsushima K, Ting JP: Identification of tumor-specific paclitaxel (Taxol)-responsive regulatory elements in the interleukin-8 promoter. Mol Cell Biol 17: 5097–5105, 1997

    Google Scholar 

  21. Mullins DW, Burger CJ, Elgert KD: Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. J Immunol 162: 6811–6818, 1999

    Google Scholar 

  22. Rao P, Falk LA, Dougherty SF, Sawada T, Pluznik DH: Colchicine down-regulates lipopolysaccharide-induced granulocyte-macrophage colony-stimulating factor production in murine macrophages. J Immunol 159: 3531–3539, 1997

    Google Scholar 

  23. Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D: Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 87: 21–27, 2002

    Google Scholar 

  24. Barten MJ, Gummert JF, van Gelder T, Shorthouse R, Morris RE: Flow cytometric quantitation of calcium-dependent and-independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro. J Immunol Methods 253: 95–112, 2001

    Google Scholar 

  25. Barten MJ, van Gelder T, Gummert JF, Shorthouse R, Morris RE: Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo. Transpl Immunol 10: 1–14, 2002

    Google Scholar 

  26. Gummert JF, Barten MJ, van Gelder T, Billingham ME, Morris RE: Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology. Transplantation 70: 1038–1049, 2000

    Google Scholar 

  27. Morris GF, Mathews MB: Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 264: 13856–13864, 1989

    Google Scholar 

  28. Shapiro DN, Adams BS, Niederhuber JE: Antigen-specific T cell activation results in an increase in cytoplasmic free calcium. J Immunol 135: 2256–2261, 1985

    Google Scholar 

  29. Novak EJ, Rabinovitch PS: Improved sensitivity in flow cytometric intracellular ionized calcium measurement using fluo-3 fura red fluorescence ratios. Cytometry 17: 135–141, 1994

    Google Scholar 

  30. Baran J, Kowalczyk D, Ozog M, Zembala M: Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation. Clin Diagn Lab Immunol 8: 303–313, 2001

    Google Scholar 

  31. Rosing H, Lustig V, van Warmerdam LJ, Huizing MT, Bokkel Huinink WW, Schellens JH, Rodenhuis S, Bult A, Beijnen JH: Pharmacokinetics and metabolism of docetaxel administered as a 1–h intravenous infusion. Cancer Chemother Pharmacol 45: 213–218, 2000

    Google Scholar 

  32. Eckert K, Fuhrmann-Selter T, Maurer HR: Docetaxel enhances the expression of E-cadherin and carcinoembryonic antigen (CEA) on human colon cancer cell lines in vitro. Anticancer Res 17: 7–12, 1997

    Google Scholar 

  33. Distefano M, Scambia G, Ferlini C, Gaggini C, De Vincenzo R, Riva A, Bombardelli E, Ojima I, Fattorossi A, Panici PB, Mancuso S: Anti-proliferative activity of a new class of taxanes (14beta-hydroxy-10–deacetylbaccatin III derivatives) on multidrug-resistance-positive human cancer cells. Int J Cancer 72: 844–850, 1997

    Google Scholar 

  34. Wang LG, Liu XM, Kreis W, Budman DR: The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 44: 355–361, 1999

    Google Scholar 

  35. Lynch K, Fernandez G, Pappalardo A, Peluso JJ: Basic fibroblast growth factor inhibits apoptosis of spontaneously immortalized granulosa cells by regulating intracellular free calcium levels through a protein kinase Cdelta-dependent pathway. Endocrinology 141: 4209–4217, 2000

    Google Scholar 

  36. Kruman I, Guo Q, Mattson MP: Calcium and reactive oxygen species mediate staurosporine-induced mitochondrial dysfunction and apoptosis in PC12 cells. J Neurosci Res 51: 293–308, 1998

    Google Scholar 

  37. Shen HM, Dong SY, Ong CN: Critical role of calcium overloading in cadmium-induced apoptosis in mouse thymocytes. Toxicol Appl Pharmacol 171: 12–19, 2001

    Google Scholar 

  38. White CM, Martin BK, Lee LF, Haskill JS, Ting JP: Effects of paclitaxel on cytokine synthesis by unprimed human monocytes, T lymphocytes, and breast cancer cells. Cancer Immunol Immunother 46: 104–112, 1998

    Google Scholar 

  39. Negulescu PA, Shastri N, Cahalan MD: Intracellular calcium dependence of gene expression in single T lymphocytes. Proc Natl Acad Sci USA 91: 2873–2877, 1994

    Google Scholar 

  40. Foss FM: Immunologic mechanisms of antitumor activity. Seminars in Oncology 29: 5–11, 2002

    Google Scholar 

  41. Patel N, Salifu M, Sumrani N, Distant D, Hong J, Markell M, Braverman AS: Successful treatment of post-renal transplant Kaposi's sarcoma with paclitaxel. Am J Transplant 2: 877–879, 2002

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Transplantation Immunology Laboratory, Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA

    Ming-Sing Si, Bari Holm, Bruce A. Reitz & Dominic C. Borie

  2. UCI Transplantation Laboratory, Division of Hepatobiliary and Pancreas Surgery and Islet Cell Transplantation, Department of Surgery, University of California, Irvine, Orange, CA

    David K. Imagawa, Ping Ji, Xunbin Wei, Jennifer Kwok & Michael Lee

  3. Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Xunbin Wei

Authors
  1. Ming-Sing Si
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David K. Imagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ping Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xunbin Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bari Holm
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jennifer Kwok
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michael Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bruce A. Reitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Dominic C. Borie
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Si, MS., Imagawa, D.K., Ji, P. et al. Immunomodulatory effects of docetaxel on human lymphocytes. Invest New Drugs 21, 281–290 (2003). https://doi.org/10.1023/A:1025408425660

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025408425660

Search

Navigation